Uterine artery closure at the origin vs at the uterus level in total laparoscopic hysterectomy: A randomized controlled trial.


Journal

Acta obstetricia et gynecologica Scandinavica
ISSN: 1600-0412
Titre abrégé: Acta Obstet Gynecol Scand
Pays: United States
ID NLM: 0370343

Informations de publication

Date de publication:
Oct 2021
Historique:
revised: 19 07 2021
received: 07 06 2021
accepted: 01 08 2021
pubmed: 17 8 2021
medline: 28 9 2021
entrez: 16 8 2021
Statut: ppublish

Résumé

The transfusion rate in hysterectomies for benign pathology is almost 3%. However, despite the strong interest in reducing intraoperative bleeding, limited evidence is available regarding the technical aspects concerning uterine vessel management during a total laparoscopic hysterectomy (TLH). Uterine artery (UA) closure in TLH can be performed at the origin from the internal iliac artery or at the uterus level (UL). However, low-quality evidence is available regarding the superiority of one method over the other. We performed a single-blind randomized (1:1) controlled trial (NCT04156932) between December 2019 and August 2020. One hundred and eighty women undergoing TLH for benign gynecological diseases were randomized to TLH with UA closure at the origin from the internal iliac artery (n = 90), performed at the beginning of the procedure by putting two clips per side at the origin, vs closure at the UL (n = 90). Intraoperative blood loss estimated from suction devices was the primary outcome. Secondary end points were perioperative outcomes, the conversion rate from one technique to the other, and complication rates with 4 months of follow up. Uterine artery closure at the origin was completed in all 90 patients (0%), whereas closure at the UL was converted to closure at the origin in 11 cases (12.2%; p < 0.001); failures were mainly associated with the presence of endometriosis (81.8% [9/11] vs 10.1% [8/79]; p < 0.001). In the intention-to-treat analysis, the intraoperative blood loss was higher in the group assigned to the closure at the UL (108.5 mL) than in the group with closure at the origin (69.3 mL); the mean difference was 39.2 mL (95% CI 13.47-64.93 mL; p = 0.003). Other perioperative outcomes and complications rates did not differ. Uterine artery closure at the origin reduces intraoperative blood loss during a TLH and appears to be more reproducible than closure at the UL without higher complication rates. However, the absent translation in clinical benefits impedes the support of a clinical superiority in all women. Closure at the origin may provide clinical advantages in the presence of severe preoperative anemia or pelvic anatomic distortion.

Identifiants

pubmed: 34396512
doi: 10.1111/aogs.14238
doi:

Types de publication

Journal Article Randomized Controlled Trial

Langues

eng

Sous-ensembles de citation

IM

Pagination

1840-1848

Informations de copyright

© 2021 The Authors. Acta Obstetricia et Gynecologica Scandinavica published by John Wiley & Sons Ltd on behalf of Nordic Federation of Societies of Obstetrics and Gynecology (NFOG).

Références

Morgan DM, Kamdar NS, Swenson CW, Kobernik EK, Sammarco AG, Nallamothu B. Nationwide trends in the utilization of and payments for hysterectomy in the United States among commercially insured women. Am J Obstet Gynecol. 2018;218:425.e1-425.e18.
Aarts JWM, Nieboer TE, Johnson N, et al. Surgical approach to hysterectomy for benign gynaecological disease. Cochrane Database Syst Rev. 2015;8:CD003677.
Uccella S, Cromi A, Bogani G, Casarin J, Formenti G, Ghezzi F. Systematic implementation of laparoscopic hysterectomy independent of uterus size: clinical effect. J Minim Invasive Gynecol. 2013;20:505-516.
Uccella S, Casarin J, Morosi C, et al. Hysterectomy for uteri weighing ≥1kg: laparoscopic vs. open approach. J Minim Invasive Gynecol. 2015;22:S87.
Uccella S, Casarin J, Marconi N, et al. Laparoscopic versus open hysterectomy for benign disease in women with giant uteri (≥1500 g): feasibility and outcomes. J Minim Invasive Gynecol. 2016;23:922-927.
Uccella S, Morosi C, Marconi N, et al. Laparoscopic versus open hysterectomy for benign disease in uteri weighing >1 kg: a retrospective analysis on 258 patients. J Minim Invasive Gynecol. 2018;25:62-69.
Uccella S, Cromi A, Serati M, Casarin J, Sturla D, Ghezzi F. Laparoscopic hysterectomy in case of uteri weighing ≥1 kilogram: a series of 71 cases and review of the literature. J Minim Invasive Gynecol. 2014;21:460-465.
Uccella S, Malzoni M, Cromi A, et al. Laparoscopic vs transvaginal cuff closure after total laparoscopic hysterectomy: a randomized trial by the Italian Society of Gynecologic Endoscopy. Am J Obstet Gynecol. 2018;218:500.e1-500.e13.
Uccella S, Zorzato PC, Kho RM. Incidence and prevention of vaginal cuff dehiscence after laparoscopic and robotic hysterectomy: a systematic review and meta-analysis. J Minim Invasive Gynecol. 2021;28:710-720.
Pan H-S, Ko M-L, Huang L-W, Chang J-Z, Hwang J-L, Chen S-C. Total laparoscopic hysterectomy (TLH) versus coagulation of uterine arteries (CUA) at their origin plus total laparoscopic hysterectomy (TLH) for the management of myoma and adenomyosis. Minim Invasive Ther Allied Technol. 2008;17:318-322.
Kale A, Aksu S, Terzi H, Demirayak G, Turkay U, Sendag F. Uterine artery ligation at the beginning of total laparoscopic hysterectomy reduces total blood loss and operation duration. J Obstet Gynaecol. 2015;35:612-615.
Yen Y-K, Liu W-M, Yuan C-C, Ng H-T. Comparison of two procedures for laparoscopic-assisted vaginal hysterectomy of large myomatous uteri. J Am Assoc Gynecol Laparosc. 2002;9:63-69.
Gingold JA, Chichura A, Harnegie MP, Kho RM. Perioperative interventions to minimize blood loss at the time of hysterectomy for uterine leiomyomas: a systematic review and meta-analysis. J Minim Invasive Gynecol. 2019;26:1234-1252.e1.
Schulz KF, Altman DG, Moher D; CONSORT Group. CONSORT 2010 statement: updated guidelines for reporting parallel group randomized trials. Obstet Gynecol. 2010;115:1063-1070.
Holub Z, Jabor A, Lukac J, Kliment L, Urbanek S. Laparoscopic myomectomy with lateral dissection of the uterine artery. JSLS. 2005;9:447-453.
Holub Z, Lukac J, Kliment L, Urbanek S. Variability of the origin of the uterine artery: laparoscopic surgical observation. J Obstet Gynaecol Res. 2005;31:158-163.
Ercoli A, Delmas V, Iannone V, et al. The lymphatic drainage of the uterine cervix in adult fresh cadavers: anatomy and surgical implications. Eur J Surg Oncol. 2010;36:298-303.
Committee opinion no 701: choosing the route of hysterectomy for benign disease. Obstet Gynecol. 2017;129:e155-e159.
Wallace SK, Fazzari MJ, Chen H, Cliby WA, Chalas E. Outcomes and postoperative complications after hysterectomies performed for benign compared with malignant indications. Obstet Gynecol. 2016;128:467-475.
Brummer THI, Jalkanen J, Fraser J, et al. FINHYST, a prospective study of 5279 hysterectomies: complications and their risk factors. Hum Reprod. 2011;26:1741-1751.
Peters A, Stuparich MA, Mansuria SM, Lee TTM. Anatomic vascular considerations in uterine artery ligation at its origin during laparoscopic hysterectomies. Am J Obstet Gynecol. 2016;215:393.e1-3.
Gingold JA, Falcone T. The retroperitoneal approach to endometriosis. J Minim Invasive Gynecol. 2017;24:896.
Gingold JA, Falcone T. Retroperitoneal anatomy during excision of pelvic side wall endometriosis. J Endometr Pelvic Pain Disord. 2016;8:62-66.
Cunha FLD, Arcoverde FVL, Andres MP, et al. Laparoscopic treatment of ureteral endometriosis: a systematic review. J Minim Invasive Gynecol. 2021;28:779-787.
Sharp HT, Adelman MR. Prevention, recognition, and management of urologic injuries during gynecologic surgery. Obstet Gynecol. 2016;127:1085-1096.
Tyan P, Taher A, Carey E, et al. The effect of anemia severity on postoperative morbidity among patients undergoing laparoscopic hysterectomy for benign indications. Acta Obstet Gynecol Scand. 2020;99:112-118.
Alvarez JB, Alvarez PM, Shepherd JA. Factors associated with symptomatic anemia and indication for blood transfusion after total laparoscopic hysterectomies. J Minim Invasive Gynecol. 2015;22:S90.
Bretschneider CE, Frazzini Padilla P, Das D, Jelovsek JE, Unger CA. The impact of surgeon volume on perioperative adverse events in women undergoing minimally invasive hysterectomy for the large uterus. Am J Obstet Gynecol. 2018;219:490.e1-490.e8.
Naveiro-Fuentes M, Rodríguez-Oliver A, Fernández-Parra J, González-Paredes A, Aguilar-Romero T, Mozas-Moreno J. Effect of surgeon’s experience on complications from laparoscopic hysterectomy. J Gynecol Obstet Hum Reprod. 2018;47:63-67.

Auteurs

Stefano Uccella (S)

Division of Obstetrics and Gynecology, Department of Maternal, Neonatal and Infant Health, ASL Biella, Biella, Italy.
Department of Obstetrics and Gynecology, AOUI Verona, University of Verona, Verona, Italy.

Simone Garzon (S)

Department of Obstetrics and Gynecology, AOUI Verona, University of Verona, Verona, Italy.

Gabriele Lanzo (G)

Division of Obstetrics and Gynecology, Department of Maternal, Neonatal and Infant Health, ASL Biella, Biella, Italy.

Davide Gallina (D)

Division of Obstetrics and Gynecology, Department of Maternal, Neonatal and Infant Health, ASL Biella, Biella, Italy.

Mariachiara Bosco (M)

Department of Obstetrics and Gynecology, AOUI Verona, University of Verona, Verona, Italy.

Irene Porcari (I)

Department of Obstetrics and Gynecology, AOUI Verona, University of Verona, Verona, Italy.

Salvatore Gueli-Alletti (S)

Division of Gynecologic Oncology, Department of Women and Children's Health, A. Gemelli University Hospital and Institute for Research and Care, Rome, Italy.

Stefano Cianci (S)

Unit of Gynecology, Department of Human Pathology of Adult and Childhood "G. Barresi", University of Messina, Messina, Italy.

Massimo Franchi (M)

Department of Obstetrics and Gynecology, AOUI Verona, University of Verona, Verona, Italy.

Pier Carlo Zorzato (PC)

Division of Obstetrics and Gynecology, Department of Maternal, Neonatal and Infant Health, ASL Biella, Biella, Italy.
Department of Obstetrics and Gynecology, AOUI Verona, University of Verona, Verona, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH